Literature DB >> 4904067

Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains.

A M Denman, A S Russell, E J Denman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4904067      PMCID： PMC1579151     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  48 in total

1.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

2.  Central and peripheral effects of anti-lymphocyte sera.

Authors:  J L Turk; D A Willoughby
Journal:  Lancet       Date:  1967-02-04       Impact factor: 79.321

3.  Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice.

Authors:  A M Denman; E P Frenkel
Journal:  Immunology       Date:  1968-01       Impact factor: 7.397

4.  Increased tumour induction by adenovirus type 12 in thymectomized mice and mice treated with anti-lymphocyte serum.

Authors:  A C Allison; L D Berman; R H Levey
Journal:  Nature       Date:  1967-07-08       Impact factor: 49.962

5.  Further experiments on the action of antilymphocytic antiserum.

Authors:  R H Levey; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

6.  Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice.

Authors:  A S Russell; A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

7.  Vascular changes in the kidneys of NZB mice and F1 NZBxNZW hybrids.

Authors:  J D Hicks
Journal:  J Pathol Bacteriol       Date:  1966-04

8.  Erythrocyte survival in normal mice and in mice with autoimmune haemolytic anaemia.

Authors:  E S Lindsey; G W Donaldson; M F Woodruff
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

9.  Analysis of the histocompatibility-2 (H-2) locus of NZB mice.

Authors:  J Klein; J Martínková; L A Herzenberg
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

10.  Chronic allogeneic disease. I. Development of glomerulonephritis.

Authors:  R M Lewis; M Y Armstrong; J André-Schwartz; A Muftuoglu; L Beldotti; R S Schwartz
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307
View more
  13 in total

Review 1.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

Review 2.  The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

Authors:  Irving L Weissman; Judith A Shizuru
Journal:  Blood       Date:  2008-11-01       Impact factor: 22.113

Review 3.  Mechanisms of tolerance and autoimmunity.

Authors:  A C Allison
Journal:  Ann Rheum Dis       Date:  1973-07       Impact factor: 19.103

4.  Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody.

Authors:  A M Denman; A S Russell; E J Denman
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

5.  Renal disease in (NZB x NZW) F1 mice treated with antilymphocytic antibody. II. Effects of restoration with isogeneic, allogeneic, and xenogeneic lymphoid cells.

Authors:  A M Denman; A S Russell; E J Denman
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

6.  Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZBxNZW) F1 hybrid mice.

Authors:  B M Greenwood; A Voller
Journal:  Clin Exp Immunol       Date:  1970-12       Impact factor: 4.330

7.  Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice.

Authors:  C C Bernard
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

Review 8.  Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.

Authors:  A Tyndall; R Saccardi
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

9.  Immunopathology of New Zealand Black mice treated with antilymphocyte globulin.

Authors:  A M Denman; A S Russell; G Loewi; E J Denman
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

10.  The disease of the NZB mouse. Examination of exchange ovum transplantation derived NZB and CFW mice.

Authors:  R D Barnes; M Tuffrey; J Kingman; R A Risdon
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.